Showing results (631-640 of 1,030) with videos related to
Sort By:
Pageof 103
The Lancet. Respiratory Medicine|August 25, 2015
Incidence of medically attended influenza during pandemic and post-pandemic seasons through the Influenza Incidence Surveillance Project, 2009-13Ashley Fowlkes, Andrea Steffens, Jon Temte, et al.The Lancet. Respiratory Medicine|December 8, 2014
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trialAlberto Papi, Brunilda Marku, Nicola Scichilone, et al.The Lancet. Respiratory Medicine|July 26, 2015
The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysisTimothy J Kidd, Ricardo J Soares Magalhães, Stuart Paynter, et al.The Lancet. Respiratory Medicine|July 26, 2015
Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trialGregory L Calligaro, Grant Theron, Hoosain Khalfey, et al.The Lancet. Respiratory Medicine|December 6, 2014
Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trialAdrian R Martineau, Wai Yee James, Richard L Hooper, et al.The Lancet. Respiratory Medicine|November 20, 2020
Trajectories of asthma and allergies from 7 years to 53 years and associations with lung function and extrapulmonary comorbidity profiles: a prospective cohort studyDinh S Bui, Caroline J Lodge, Jennifer L Perret, et al.The Lancet. Respiratory Medicine|September 10, 2020
The genetics of asthma and the promise of genomics-guided drug target discoveryZaid W El-Husseini, Reinoud Gosens, Frank Dekker, et al.The Lancet. Respiratory Medicine|February 17, 2020
Small airways pathology in idiopathic pulmonary fibrosis: a retrospective cohort studyStijn E Verleden, Naoya Tanabe, John E McDonough, et al.The Lancet. Respiratory Medicine|February 19, 2020
Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy studyHridesh Mishra, Byron W P Reeve, Zaida Palmer, et al.The Lancet. Respiratory Medicine|February 29, 2020
Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trialJaclyn A Smith, Michael M Kitt, Alyn H Morice, et al.Pageof 103